Is the world prepared to fight the next Ebola outbreak? NewsHour provides an update on Ebola vaccine testing in West Africa.
By Caleb Hellerman, Global Health Reporting Center
The National Institutes of Health will begin testing an experimental Ebola vaccine on an initial 20 adult humans this week, as the lethal virus’ reach “continues to accelerate” in West Africa.
By Joshua Barajas
Should doctors be paid by pharmaceutical companies to promote their drugs?…
An experimental vaccine against malaria, an oftentimes-deadly disease that half the world is exposed to, is still in trials, but it could be in production by 2015. Jeffrey Brown discusses the potential impact of the vaccine with GlaxoSmithKline CEO Andrew…
Health correspondent Betty Ann Bowser reports on the safety concerns surrounding the diabetes drug Avandia after U.S. health advisers recommended it stay on the market with increased warnings to consumers despite associated heart risks.
Between 60,000 and 80,000 Tanzanians die from malaria each year. In the last installment in his series of reports from Tanzania, Ray Suarez looks at a mult-million-dollar effort to slow the spread of the disease through the distribution of bed…
Malaria kills one African child about every 30 seconds. Now, a vaccine developed by GlaxoSmithKline and the Bill and Melinda Gates Foundation shows promise in reducing the rate of severe malaria by as much as 50 percent. Susan Dentzer reports…
A study released Monday in the New England Journal of Medicine suggests that the diabetes drug Avandia increases the risk of heart attack. NewsHour health correspondent Susan Dentzer explains the findings.
New York Attorney General Eliot Spitzer filed suit against GlaxoSmithKline on Wednesday, alleging the British drug maker withheld unfavorable data on treating children with its antidepressant Paxil.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.